The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Alterations in the Ca2+ toolkit in oesophageal adenocarcinoma”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Zhigang Chen, Zhenheng Wu, Tianhan Xu, Fuqian Yu, Dongmei Wang. TRPM2: a pivotal player in tumor progression and a promising therapeutic target, Cancer Cell International. 2025; 25: 356. https://doi.org/10.1186/s12935-025-03974-w |
|
2 |
2024 |
Xuerun Liu, Boqiang Shen, Jingyi Zhou, Juan Hao, Jianliu Wang. The L‐type calcium channel CaV1.3: A potential target for cancer therapy, Journal of Cellular and Molecular Medicine. 2024; 28: e70123. https://doi.org/10.1111/jcmm.70123 |
|
3 |
2024 |
Yuto Numata, Noriyuki Akutsu, Masashi Idogawa, Kohei Wagatsuma, Yasunao Numata, Keisuike Ishigami, Tomoya Nakamura, Takehiro Hirano, Yujiro Kawakami, Yoshiharu Masaki, Ayako Murota, Shigeru Sasaki, Hiroshi Nakase. Genomic analysis of an aggressive hepatic leiomyosarcoma case following treatment for hepatocellular carcinoma, Hepatology Research. 2024; 54: 859. https://doi.org/10.1111/hepr.14034 |
|
4 |
2026 |
Lou Freuville, Chloé Matthys, Quentin Gilliaux, Lionel D’Hondt, Jean-Pierre Gillet. Could venom-derived therapeutics resolve treatment resistance in refractory EAC?, Trends in Molecular Medicine. 2026; https://doi.org/10.1016/j.molmed.2026.03.007 |